The Development of Investigator-Initiated Clinical Trials in Surgical Oncology

Hannah G. McDonald, Emily B. Cassim, Megan M. Harper, Erin E. Burke, Emily F. Marcinkowski, Michael J. Cavnar, Prakash K. Pandalai, Joseph Kim

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)13-25
Number of pages13
JournalSurgical Oncology Clinics of North America
Volume32
Issue number1
DOIs
StatePublished - Jan 2023

Bibliographical note

Funding Information:
This research was supported by NIH training grant T32CA160003 (M.M. Harper). P.K. Pandalai received research funding from the University of Kentucky (UK) Markey Cancer Center (MCC) to conduct clinical trial NCT04779554. M.J. Cavnar received research funding from the UK MCC and the American Cancer Society to conduct clinical trial NCT04276090. E.F. Marcinkowski received research funding from the UK MCC to conduct clinical trial NCT05150652. J. Kim received research funding from Merck and Exelixis to conduct clinical trial NCT05052723 and Ipsen to conduct clinical trial NCT04088786.

Keywords

  • Clinical trial protocol development
  • Investigator-initiated trials
  • Surgical oncology

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'The Development of Investigator-Initiated Clinical Trials in Surgical Oncology'. Together they form a unique fingerprint.

Cite this